Skip to content

Clinical trials

Phase 1 Renal Insufficiency, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 1 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20111
20131
20151
20173
20192
20201
20213
20222
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated3
Recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer9
AstraZeneca4
Novo Nordisk A/S3
Amgen2
Boehringer Ingelheim1
Eli Lilly and Company1
Novartis Pharmaceuticals1
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic22
Hyperparathyroidism, Secondary2
Hypertension2
Kidney Failure, Chronic2
Acute Kidney Injury1
Atherosclerosis1
Bacterial Infections1
Diabetes Mellitus, Type 21
Obesity1
Renal Insufficiency1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.